Skip to main content
Top
Published in: The European Journal of Health Economics 4/2011

01-08-2011 | Original Paper

Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges

Authors: Raymond Oppong, Joanna Coast, Kerry Hood, Jacqui Nuttall, Richard D. Smith, Christopher C. Butler

Published in: The European Journal of Health Economics | Issue 4/2011

Login to get access

Abstract

The objectives of this study were to estimate the resource use and cost of treating acute cough/lower respiratory tract infection (acute cough/LRTI) in 13 European countries, to explore reasons for differences in cost and to document the challenges that researchers face when collecting information on cost alongside multinational studies. Data on resource use and cost were collected alongside an observational study in 14 primary care networks across 13 European countries and a mean cost was generated for each network. The results show that the mean cost (standard deviation) of treating acute cough/LRTI in Europe ranged from €23.88 (34.67) in Balatonfüred (Hungary) to €116.47 (34.29) in Jonkoping (Sweden). The observed differences in costs were statistically significant (P < 0.01). Major cost drivers include general practitioner visits and drug costs in all networks, whilst differences in health systems and regional factors could account for differences in cost between networks. The major barrier to conducting multinational cost studies are barriers associated with identifying cost information.
Literature
1.
go back to reference Ball, P., et al.: Antibiotic therapy of community acquired lower respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49, 31–40 (2002)PubMedCrossRef Ball, P., et al.: Antibiotic therapy of community acquired lower respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49, 31–40 (2002)PubMedCrossRef
2.
go back to reference Ortqvist, A.: Treatment of community acquired lower respiratory tract infections in adults. Eur. Respir. J. 20(Suppl 36), 40S–53S (2002)CrossRef Ortqvist, A.: Treatment of community acquired lower respiratory tract infections in adults. Eur. Respir. J. 20(Suppl 36), 40S–53S (2002)CrossRef
3.
go back to reference Ehlke, B., et al.: Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur. J. Pediatr. 164(10), 607–615 (2005)CrossRef Ehlke, B., et al.: Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur. J. Pediatr. 164(10), 607–615 (2005)CrossRef
4.
go back to reference Guest, J.F., Morris, A.: Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur. Respir. J. 10, 1530–1534 (1997) Guest, J.F., Morris, A.: Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur. Respir. J. 10, 1530–1534 (1997)
5.
go back to reference Guthrie, R.: Community acquired lower respiratory tract infections: etiology and treatment. Chest 120, 2021–2034 (2001)PubMedCrossRef Guthrie, R.: Community acquired lower respiratory tract infections: etiology and treatment. Chest 120, 2021–2034 (2001)PubMedCrossRef
7.
go back to reference Hak, E., et al.: Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam. Pract. 22, 375–380 (2005)PubMedCrossRef Hak, E., et al.: Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam. Pract. 22, 375–380 (2005)PubMedCrossRef
8.
go back to reference Cals, J.W.L., et al.: Improving management of patients with acute cough by C-reactive protein point of care testing and community training (IMPACT): study protocol of a cluster randomised controlled trial. BMC Fam. Pract. 8, 15 (2007)PubMedCrossRef Cals, J.W.L., et al.: Improving management of patients with acute cough by C-reactive protein point of care testing and community training (IMPACT): study protocol of a cluster randomised controlled trial. BMC Fam. Pract. 8, 15 (2007)PubMedCrossRef
9.
go back to reference Gjelstad, S., et al.: Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice—the prescribing peer academic detailing study. BMC Health Serv. Res. 6, 75 (2006)PubMedCrossRef Gjelstad, S., et al.: Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice—the prescribing peer academic detailing study. BMC Health Serv. Res. 6, 75 (2006)PubMedCrossRef
10.
go back to reference Goosens, H., et al.: National campaigns to improve antibiotic use. Eur. J. Clin. Pharmacol. 62, 373–379 (2006)CrossRef Goosens, H., et al.: National campaigns to improve antibiotic use. Eur. J. Clin. Pharmacol. 62, 373–379 (2006)CrossRef
11.
go back to reference Coenen, S., et al.: Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J. Antimicrob. Chemother. 54, 661–672 (2004)PubMedCrossRef Coenen, S., et al.: Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J. Antimicrob. Chemother. 54, 661–672 (2004)PubMedCrossRef
12.
go back to reference Van Driel, M.L., et al.: What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual. Saf. Health Care 16, 197–202 (2007)PubMedCrossRef Van Driel, M.L., et al.: What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual. Saf. Health Care 16, 197–202 (2007)PubMedCrossRef
13.
go back to reference Kristinsson, K.G.: Effects of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3, 117–123 (1997)PubMedCrossRef Kristinsson, K.G.: Effects of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3, 117–123 (1997)PubMedCrossRef
14.
go back to reference Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.M., Huber, P.R., Tamm, M., Muller, B.: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Cluster randomised, single blinded intervention trial. Lancet 363, 600–607 (2004)PubMedCrossRef Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.M., Huber, P.R., Tamm, M., Muller, B.: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Cluster randomised, single blinded intervention trial. Lancet 363, 600–607 (2004)PubMedCrossRef
15.
go back to reference Manca, A., et al.: Assessing the generalizability by location in trial based cost-effectiveness analysis: the use of multilevel models. Health Econ. 14, 471–485 (2005)PubMedCrossRef Manca, A., et al.: Assessing the generalizability by location in trial based cost-effectiveness analysis: the use of multilevel models. Health Econ. 14, 471–485 (2005)PubMedCrossRef
16.
go back to reference Pang, F.: Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics 20(2), 75–90 (2002)PubMedCrossRef Pang, F.: Design, analysis and presentation of multinational economic studies: the need for guidance. Pharmacoeconomics 20(2), 75–90 (2002)PubMedCrossRef
17.
go back to reference Raikou, M., et al.: Centre specific or average unit costs in multinational clinical trials? Some theory and simulation. Health Econ. 9, 191–198 (2000)PubMedCrossRef Raikou, M., et al.: Centre specific or average unit costs in multinational clinical trials? Some theory and simulation. Health Econ. 9, 191–198 (2000)PubMedCrossRef
18.
go back to reference Virk, K.P.: Global clinical trials: the challenge of language. Drug Inform. Assoc. 44(4), 21–23 (2008) Virk, K.P.: Global clinical trials: the challenge of language. Drug Inform. Assoc. 44(4), 21–23 (2008)
19.
go back to reference Schulman, K., et al.: Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 7, 629–638 (1998)PubMedCrossRef Schulman, K., et al.: Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 7, 629–638 (1998)PubMedCrossRef
20.
go back to reference Wordsworth, S., et al.: Collecting unit costs data in multicentre studies creating comparable methods European. J. Health Econ. 50, 38–44 (2005) Wordsworth, S., et al.: Collecting unit costs data in multicentre studies creating comparable methods European. J. Health Econ. 50, 38–44 (2005)
21.
go back to reference Koopmanscap, M.A., et al.: Analysis of cost and cost-effectiveness in multinational trials. Health Policy 58, 175–186 (2001)CrossRef Koopmanscap, M.A., et al.: Analysis of cost and cost-effectiveness in multinational trials. Health Policy 58, 175–186 (2001)CrossRef
22.
go back to reference Butler, C.C., et al.: Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009)PubMedCrossRef Butler, C.C., et al.: Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009)PubMedCrossRef
25.
go back to reference Donner, A., Klar, N.: Design and analysis of cluster randomization trials in health research. Hodder Arnold, London (2000) Donner, A., Klar, N.: Design and analysis of cluster randomization trials in health research. Hodder Arnold, London (2000)
26.
go back to reference Rurik, I.: Primary care diabetes in Hungary. Prim. Care Diabetes 177–179 (2007) Rurik, I.: Primary care diabetes in Hungary. Prim. Care Diabetes 177–179 (2007)
27.
go back to reference Little, P.: Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 331, 301–302 (2005)PubMedCrossRef Little, P.: Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 331, 301–302 (2005)PubMedCrossRef
28.
go back to reference NICE.: Respiratory tract infections—antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. http://www.nice.org.uk (2008) NICE.: Respiratory tract infections—antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. http://​www.​nice.​org.​uk (2008)
29.
go back to reference De Smet, P.: Herbal medicine in Europe—relaxing regulatory standards. N. Engl. J. Med. 352, 1176–1178 (2005)PubMedCrossRef De Smet, P.: Herbal medicine in Europe—relaxing regulatory standards. N. Engl. J. Med. 352, 1176–1178 (2005)PubMedCrossRef
30.
go back to reference Goosens, H., et al.: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587 (2005) Goosens, H., et al.: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587 (2005)
31.
go back to reference Grytten, J., Sorensen, R.: Type of contract and supplier—induced demand for primary physicians in Norway. J. Health Econ. 20, 379–393 (2001)PubMedCrossRef Grytten, J., Sorensen, R.: Type of contract and supplier—induced demand for primary physicians in Norway. J. Health Econ. 20, 379–393 (2001)PubMedCrossRef
32.
go back to reference Birnbaum, H.G., et al.: Lower respiratory tract infections impact on the workplace. Pharmacoeconomics 21(10), 749–759 (2003)PubMedCrossRef Birnbaum, H.G., et al.: Lower respiratory tract infections impact on the workplace. Pharmacoeconomics 21(10), 749–759 (2003)PubMedCrossRef
33.
go back to reference Cook, J.R., et al.: Assessing the appropriateness of combining economic data from multinational clinical trials. Stat. Med. 22, 1955–1976 (2003)PubMedCrossRef Cook, J.R., et al.: Assessing the appropriateness of combining economic data from multinational clinical trials. Stat. Med. 22, 1955–1976 (2003)PubMedCrossRef
34.
go back to reference Reed, S.D., et al.: Conducting economic evaluations alongside multinational clinical trials: towards a research consensus. Am. Heart J. 149(3), 434–443 (2005)PubMedCrossRef Reed, S.D., et al.: Conducting economic evaluations alongside multinational clinical trials: towards a research consensus. Am. Heart J. 149(3), 434–443 (2005)PubMedCrossRef
35.
go back to reference Epstein, D., et al.: The hospital care for stroke in nine European countries. Health Econ. 17, S21–S31 (2008)PubMedCrossRef Epstein, D., et al.: The hospital care for stroke in nine European countries. Health Econ. 17, S21–S31 (2008)PubMedCrossRef
Metadata
Title
Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges
Authors
Raymond Oppong
Joanna Coast
Kerry Hood
Jacqui Nuttall
Richard D. Smith
Christopher C. Butler
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 4/2011
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-010-0239-1

Other articles of this Issue 4/2011

The European Journal of Health Economics 4/2011 Go to the issue